Anaptysbio (ANAB) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to $0.52.
- Anaptysbio's EPS (Weighted Average and Diluted) rose 14561.4% to $0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.76, marking a year-over-year increase of 5460.53%. This contributed to the annual value of -$5.12 for FY2024, which is 1583.86% up from last year.
- Per Anaptysbio's latest filing, its EPS (Weighted Average and Diluted) stood at $0.52 for Q3 2025, which was up 14561.4% from -$1.34 recorded in Q2 2025.
- In the past 5 years, Anaptysbio's EPS (Weighted Average and Diluted) registered a high of $0.52 during Q3 2025, and its lowest value of -$1.71 during Q2 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$1.05, with a median of -$1.19 in 2021.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 724257.58% in 2022, then skyrocketed by 14561.4% in 2025.
- Quarter analysis of 5 years shows Anaptysbio's EPS (Weighted Average and Diluted) stood at -$1.19 in 2021, then surged by 33.96% to -$0.79 in 2022, then crashed by 102.32% to -$1.59 in 2023, then surged by 51.73% to -$0.77 in 2024, then surged by 167.75% to $0.52 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.52 for Q3 2025, versus -$1.34 for Q2 2025 and -$1.28 for Q1 2025.